SEC 13F Intelligence

Two Seas Capital LP / ESPR

Two Seas Capital LP’s Esperion Therapeutics Inc Ne Position

Does Two Seas Capital LP own Esperion Therapeutics Inc Ne (ESPR)? Yes — 11.39M shares worth $31M (+0.44% of its 13F portfolio) as of Q1 2026, down from 11.90M shares the prior filed quarter.

Position Value
$31M
Q1 2026
Shares
11.39M
% of Portfolio
+0.44%
Quarters Held
12
currently held

Position History ESPR

Reported value by quarter
Q2 ’23: $4MQ2 ’23Q3 ’23: $8MQ4 ’23: $23MQ4 ’23Q1 ’24: $11MQ2 ’24: $13MQ2 ’24Q3 ’24: $11MQ4 ’24: $14MQ4 ’24Q1 ’25: $10MQ2 ’25: $10MQ2 ’25Q3 ’25: $26MQ4 ’25: $44MQ4 ’25Q1 ’26: $31Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202611.39M$31M+0.44%
Q4 202511.90M$44M+0.91%
Q3 20259.75M$26M+0.41%
Q2 20259.95M$10M+0.16%
Q1 20256.93M$10M+0.31%
Q4 20246.23M$14M+1.18%
Q3 20246.58M$11M+1.76%
Q2 20245.74M$13M+2.07%
Q1 20244.17M$11M+2.19%
Q4 20237.69M$23M+5.61%
Q3 20237.67M$8M+1.51%
Q2 20232.94M$4M+0.89%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Two Seas Capital LP’s full portfolio or all institutional holders of ESPR.